|
|
| Research article summary (published 17 Apr 2006): |
Modifications of coronary risk factors.
Full Abstract
In addition to the revascularization and glycemic management interventions assigned at random, the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) design includes the uniform control of major coronary artery disease risk factors, including dyslipidemia, hypertension, smoking, central obesity, and sedentary lifestyle. Target levels for risk factors were adjusted throughout the trial to comply with changes in recommended clinical practice guidelines. At present, the goals are low-density lipoprotein cholesterol <2.59 mmol/L (<100 mg/dL) with an optional goal of <1.81 mmol/L (<70 mg/dL); plasma triglyceride level <1.70 mmol/L (<150 mg/dL); blood pressure level <130 mm Hg systolic and <80 mm Hg diastolic; and smoking cessation treatment for all active smokers. Algorithms were developed for the pharmacologic management of dyslipidemia and hypertension. Dietary prescriptions for the management of glycemia, plasma lipid profiles, and blood pressure levels were adapted from existing clinical practice guidelines. Patients with a body mass index >25 were prescribed moderate caloric restriction; after the trial was under way, a lifestyle weight-management program was instituted. All patients were formally prescribed both endurance and resistance/flexibility exercises, individually adapted to their level of disability and fitness. Pedometers were distributed as a biofeedback strategy. Strategies to achieve the goals for risk factors were designed by BARI 2D working groups (lipid, cardiovascular and hypertension, and nonpharmacologic intervention) and the ongoing implementation of the strategies is monitored by lipid, hypertension, and lifestyle intervention management centers.
Learn Faster Today Improve your study skills
Author information
Author/s: Albu, Jeanine (J); Gottlieb, Sheldon H (SH); August, Phyllis (P); Nesto, Richard W (RW); Orchard, Trevor J (TJ); Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators;
Affiliation: The New York Obesity Research Center, St. Luke's-Roosevelt Hospital Center, University Hospital of Columbia University, College of Physicians and Surgeons, Columbia University, New York, New York 10025, USA. jba1(-atsign-)columbia.edu
Grants: U01 HL061746 (Agency:NHLBI NIH HHS) ; U01 HL061748 (Agency:NHLBI NIH HHS) ; U01 HL063804 (Agency:NHLBI NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: The American journal of cardiology (Am J Cardiol), published in United States. (Language: eng)
Reference: 2006-Jun; vol 97 (issue 12A) : pp 41G-52G
Dates: Created 2006/07/03; Completed 2006/08/01; Revised 2007/11/15;
PMID: 16813737, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
These are the highest related articles currently in the database:
- ESH-ESC guidelines for the management of hypertension.
30 May 2006 - [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care]
16 Dec 2005 - The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?
30 Jan 2008 - [Management of diabetes and hypertension: how do primary care physicians judge their performance?]
25 Feb 2003 - Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
5 Apr 2006 - [Nephropathy: an overview for daily practice]
25 Feb 2003 - Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
17 Apr 2006 - Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
30 Dec 2006 - Abciximab offers greater benefits to insulin-dependent diabetic patients undergoing coronary stent implantation.
29 Jun 2007 - Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
15 Apr 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.